TABLE 1 PREVALENCE OF FEW AUTOIMMUNE DISEASESIN U.S. (2012) 37

TABLE 2 PROJECT FUNDING FOR RHEUMATOID ARTHRITIS AND LUPUS

(2018-2023) (USD MILLION) 39

TABLE 3 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION) 42

TABLE 4 NORTH-AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 57
TABLE 5 NORTH-AMERICA ASSAY KITS & REAGENTS MARKET, BY REGION,

2016 - 2025 (USD MILLION) 58
TABLE 6 NORTH-AMERICA SYSTEMS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 59

TABLE 7 NORTH-AMERICA SOFTWARES MARKET, BY REGION, 2016 - 2025 (USD MILLION) 60

TABLE 8 NORTH-AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET, BY TEST,

2016 - 2025 (USD MILLION) 63
TABLE 9 NORTH-AMERICA INDIRECT IMMUNOFLUORESCENCE MARKET, BY REGION,

2016 - 2025 (USD MILLION) 64
TABLE 10 NORTH-AMERICA ELISA MARKET, BY REGION, 2016 - 2025 (USD MILLION) 65

TABLE 11 NORTH-AMERICA MULTIPLEX TESTING MARKET, BY REGION,

2016 - 2025 (USD MILLION) 66
TABLE 12 NORTH-AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 69
TABLE 13 NORTH-AMERICA RHEUMATOID ARTHRITIS MARKET, BY REGION,

2016 - 2025 (USD MILLION) 70
TABLE 14 NORTH-AMERICA SYSTEMIC LUPUS ERYTHEMATOSUS MARKET, BY REGION,

2016 - 2025 (USD MILLION) 71
TABLE 15 NORTH-AMERICA SJOGREN'S SYNDROME MARKET, BY REGION,

2016 - 2025 (USD MILLION) 72
TABLE 16 NORTH-AMERICA SCLERODERMA MARKET, BY REGION,

2016 - 2025 (USD MILLION) 73
TABLE 17 NORTH-AMERICA POLYMYOSITIS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 74

TABLE 18 NORTH-AMERICA OTHERS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 75

TABLE 19 NORTH-AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 78
TABLE 20 NORTH-AMERICA HOSPITALS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 79

TABLE 21 NORTH-AMERICA CLINICS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 80

TABLE 22 NORTH-AMERICA PHYSICIAN OFFICE LABORATORIES MARKET, BY REGION,

2016 - 2025 (USD MILLION) 81
TABLE 23 NORTH-AMERICA OTHERS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 82

TABLE 24 NORTH-AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET, BY REGION,

2016 - 2025 (USD MILLION) 90
TABLE 25 NORTH AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET,

BY COUNTRY, 2016-2025 (USD MILLION) 97

TABLE 26 NORTH AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016 - 2025 (USD MILLION) 97

TABLE 27 NORTH AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016 - 2025 (USD MILLION) 98

TABLE 28 NORTH AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016 - 2025 (USD MILLION) 99

TABLE 29 NORTH AMERICA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016 - 2025 (USD MILLION) 100

TABLE 30 U.S. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 101
TABLE 31 U.S. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 101
TABLE 32 U.S. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 102
TABLE 33 U.S. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 103
TABLE 34 CANADA ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 104
TABLE 35 CANADA ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 104
TABLE 36 CANADA ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 105
TABLE 37 CANADA ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 106
TABLE 38 MEXICO ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 107
TABLE 39 MEXICO ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 107
TABLE 40 MEXICO ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 108
TABLE 41 MEXICO ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 109

LIST OF FIGURE

Figures List
Figure 1 North-America Anti-Nuclear Antibody Test Market; Segmentation 27
Figure 2 North-America Anti-Nuclear Antibody Test Market; Data Triangulation 30
Figure 3 North-America Anti-Nuclear Antibody Test Market ; Research Snapshot 31
Figure 4 North-America Anti-Nuclear Antibody Test Market ; Bottom Up Approach 32
Figure 5 North-America Anti-Nuclear Antibody Test Market; Top Down Approach 32
Figure 6 North-America Anti-Nuclear Antibody Test Market ;
Interview Demographics 33
Figure 7 North-America Anti-Nuclear Antibody Test Market ; Segmentation 46
Figure 8 North America Is Expected To Dominate The Market For Anti-Nuclear Antibody Test And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025 47
Figure 9 North-America Anti-Nuclear Antibody Test Market; By Product Type, 2017 56
Figure 10 North-America Anti-Nuclear Antibody Test Market; By Test, 2017 62
Figure 11 North-America Anti-Nuclear Antibody Test Market; By Disease, 2017 68
Figure 12 North-America Anti-Nuclear Antibody Test Market; By End User, 2017 77
Figure 13 North-America Anti-Nuclear Antibody Test Market Snapshot (2017) 85
Figure 14 North-America Anti-Nuclear Antibody Test Market; By Geography (2017) 86
Figure 15 North-America Anti-Nuclear Antibody Test Market; By Geography (2018) 87
Figure 16 North-America Anti-Nuclear Antibody Test Market; By Country (2017 & 2025) 88
Figure 17 North-America Anti-Nuclear Antibody Test Market;
By Product Type (2018 & 2025) 89
Figure 18 North America Anti-Nuclear Antibody Test Market; Snapshot (2017) 92
Figure 19 North America Anti-Nuclear Antibody Test Market;
By Country (2017) 93
Figure 20 North America Anti-Nuclear Antibody Test Market ;
By Country (2018 & 2025) 94
Figure 21 North America Anti-Nuclear Antibody Test Market,
By Country (2018 & 2025) 95
Figure 22 North America Anti-Nuclear Antibody Test Market,
By Product (2018 & 2025) 96
Figure 23 North-America Anti-Nuclear Antibody Test Market; Company Share 2017 (%) 220
Figure 24 North America Anti-Nuclear Antibody Test Market;
Company Share 2017 (%) 221

?